This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Prosetta Antiviral, Inc.. Active years: 2012.
Company Filing History:
Years Active: 2012
Title: Colm Kelleher: Innovator in Antiviral Treatments
Introduction
Colm Kelleher is a notable inventor based in Lafayette, CA (US). He has made significant contributions to the field of antiviral treatments, focusing on innovative compounds that can combat various viral infections. His work is particularly relevant in today's world, where the need for effective antiviral solutions is more critical than ever.
Latest Patents
Colm Kelleher holds a patent for "Diamino-phenothiazinyl derivatives as antiviral treatments." This patent encompasses compounds and methods designed to prevent and treat viral infections. In particular, the novel compounds he developed exhibit broad-spectrum antiviral activity. They have shown effectiveness against viruses such as Venezuelan Equine Encephalitis, West Nile Virus, and Hepatitis C.
Career Highlights
Kelleher's career is marked by his dedication to research and innovation in the pharmaceutical field. He is currently associated with Prosetta Antiviral, Inc., where he continues to explore new avenues for antiviral therapies. His work has the potential to make a significant impact on public health.
Collaborations
Colm Kelleher collaborates with esteemed colleagues, including Vishwanath R Lingappa and Beverly Freeman. These partnerships enhance the research and development efforts at Prosetta Antiviral, Inc., fostering an environment of innovation and discovery.
Conclusion
Colm Kelleher is a pioneering inventor whose work in antiviral treatments is paving the way for new therapeutic options. His contributions are vital in the ongoing fight against viral infections, and his innovative spirit continues to inspire advancements in the field.